Hologic stock holds near a 52-week high as revenue stays firm
Published on 09/01/2026 at 15:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hologic stock (US4364401012) was quoted at $76.00 on September 1, 2026, with a market capitalization of $16.97 billion and a 52-week range of $51.90 to $76.07. The latest coverage also puts the consensus rating at Hold, with a $79.13 price target attached to current analyst models.
Revenue still carries weight
The most recent quarterly snapshot in current coverage shows January 29, 2026 earnings of $1.04 a share, which missed the $1.09 consensus by $0.05. Revenue in that report was up 2.5% from the same quarter a year earlier, a useful sign that demand is still doing enough to support the top line.
That mix matters because Hologic is still priced close to the top of its 52-week band, so investors are paying attention to whether growth can keep pace with the valuation. The current P/E ratio stands at 31.67, while the forward P/E is 17.76, a gap that shows how much of the story is still tied to earnings expectations.
What the chart says
The stock's one-day range was $76.00 to $76.07, which leaves little room between the latest trade and the year high. Volume reached 102.03 million shares in the current market snapshot, far above the 3.29 million average volume cited on the same page.
For investors, that combination of a tight range and heavy turnover suggests the market is still actively revaluing the name rather than ignoring it. It also keeps attention on whether the next quarterly update can justify the current multiple.
Hologic's product base
Hologic's diagnostics and imaging portfolio is the core of the business, with mammography, breast health, cytology and molecular diagnostics making up the company's most visible product lines. That mix gives the company exposure to recurring testing and procedure demand rather than a single product cycle.
Stock level and setup
Hologic stock was last quoted at $76.00 on September 1, 2026, versus a 52-week high of $76.07 and a low of $51.90. The market is treating that band as the key reference point while earnings expectations and valuation stay in view.
Fact box
Company: Hologic, Inc.
ISIN: US4364401012
Ticker: HOLX
Exchange: Nasdaq
Sector / Industry: Healthcare Equipment / Healthcare Equipment & Supplies
Index membership: Nasdaq-100
Price (as of September 1, 2026, 4:41 a.m. ET): $76.00 USD
Market cap: $16.97 billion
Next earnings date: November 1, 2026
